- BiotechInvestor Oct 26, 2017 at 01:28: PM
Alexion's Soliris (eculizumab) product sales up 4% to $756 mil during the September quarter. Hope the FDA approval for Soliris for Myasthenia Gravis patients will boost the sales in the coming months.
My granny has this disorder. I don't know when this drug will be available in the market?
My granny has this disorder. I don't know when this drug will be available in the market?